Publication | Open Access
Long-term Outcomes of Helper Peptide Vaccination for Metastatic Melanoma
33
Citations
35
References
2015
Year
Helper peptide vaccination is associated with improved overall survival among patients with metastatic melanoma. These data support a randomized prospective trial of the 6MHP vaccine.
| Year | Citations | |
|---|---|---|
Page 1
Page 1